184 related articles for article (PubMed ID: 35752610)
1. S100A11 activates the pentose phosphate pathway to induce malignant biological behaviour of pancreatic ductal adenocarcinoma.
Zeng X; Guo H; Liu Z; Qin Z; Cong Y; Ren N; Zhang Y; Zhang N
Cell Death Dis; 2022 Jun; 13(6):568. PubMed ID: 35752610
[TBL] [Abstract][Full Text] [Related]
2. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of Mobility in Pancreatic Cancer Cells by Secreted S100A11 Through Activation of Surrounding Fibroblasts.
Mitsui Y; Tomonobu N; Watanabe M; Kinoshita R; Sumardika IW; Youyi C; Murata H; Yamamoto KI; Sadahira T; Rodrigo AGH; Takamatsu H; Araki K; Yamauchi A; Yamamura M; Fujiwara H; Inoue Y; Futami J; Saito K; Iioka H; Kondo E; Nishibori M; Toyooka S; Yamamoto Y; Nasu Y; Sakaguchi M
Oncol Res; 2019 Aug; 27(8):945-956. PubMed ID: 31046874
[TBL] [Abstract][Full Text] [Related]
4. Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.
Takamatsu H; Yamamoto KI; Tomonobu N; Murata H; Inoue Y; Yamauchi A; Sumardika IW; Chen Y; Kinoshita R; Yamamura M; Fujiwara H; Mitsui Y; Araki K; Futami J; Saito K; Iioka H; Ruma IMW; Putranto EW; Nishibori M; Kondo E; Yamamoto Y; Toyooka S; Sakaguchi M
Oncol Res; 2019 Jun; 27(6):713-727. PubMed ID: 30850029
[TBL] [Abstract][Full Text] [Related]
5. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
[No Abstract] [Full Text] [Related]
6. Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer.
Ishii T; Akiyama Y; Shimada S; Kabashima A; Asano D; Watanabe S; Ishikawa Y; Ueda H; Akahoshi K; Ogawa K; Ono H; Kudo A; Tanabe M; Tanaka S
Cancer Sci; 2023 Feb; 114(2):463-476. PubMed ID: 36271761
[TBL] [Abstract][Full Text] [Related]
7. Glycolysis addiction compensating for a defective pentose phosphate pathway confers gemcitabine sensitivity in SETD2-deficient pancreatic cancer.
Shen X; Chen Y; Liu M; Shi J; Tang Y; Yang X; Xu D; Yao H; Lu P; Sun Y; Xue J; Niu N
Biochem Biophys Res Commun; 2022 Jul; 615():9-16. PubMed ID: 35679751
[TBL] [Abstract][Full Text] [Related]
8. Correlation between S100A11 and the TGF-β
Ji YF; Li T; Jiang F; Ni WK; Guan CQ; Liu ZX; Lu CH; Ni RZ; Wu W; Xiao MB
Mol Cell Biochem; 2019 Jan; 450(1-2):53-64. PubMed ID: 29922945
[TBL] [Abstract][Full Text] [Related]
9. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma.
Li HB; Wang JL; Jin XD; Zhao L; Ye HL; Kuang YB; Ma Y; Jiang XY; Yu ZY
BMC Cancer; 2021 Sep; 21(1):1039. PubMed ID: 34530774
[TBL] [Abstract][Full Text] [Related]
11. S100A14 promotes progression and gemcitabine resistance in pancreatic cancer.
Zhu H; Gao W; Li X; Yu L; Luo D; Liu Y; Yu X
Pancreatology; 2021 Apr; 21(3):589-598. PubMed ID: 33579599
[TBL] [Abstract][Full Text] [Related]
12. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
[TBL] [Abstract][Full Text] [Related]
13. AKR7A3 modulates the metastasis of pancreatic ductal adenocarcinoma through regulating PHGDH-suppressed autophagy.
Hua L; Song Y; Min J; Wang R; Li H; Zhu L; Guo Y; Gan D; Li S; Ma P; Yang C; Yang J; Shi J; Li J; Su H
Cancer Sci; 2023 Aug; 114(8):3101-3113. PubMed ID: 36951402
[TBL] [Abstract][Full Text] [Related]
14. ETV4 promotes pancreatic ductal adenocarcinoma metastasis through activation of the CXCL13/CXCR5 signaling axis.
Gao X; Jiang M; Chu Y; Han Y; Jin Y; Zhang W; Wang W; Yang S; Li W; Fan A; Cao J; Wang J; Liu H; Fu X; Chen D; Nie Y; Fan D
Cancer Lett; 2022 Jan; 524():42-56. PubMed ID: 34582976
[TBL] [Abstract][Full Text] [Related]
15. Novel transketolase inhibitor oroxylin A suppresses the non-oxidative pentose phosphate pathway and hepatocellular carcinoma tumour growth in mice and patient-derived organoids.
Jia D; Liu C; Zhu Z; Cao Y; Wen W; Hong Z; Liu Y; Liu E; Chen L; Chen C; Gu Y; Jiao B; Chai Y; Wang HY; Fu J; Chen X
Clin Transl Med; 2022 Nov; 12(11):e1095. PubMed ID: 36314067
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1.
Li S; Yan G; Yue M; Kang Z; Wang L
Mol Med Rep; 2019 Feb; 19(2):1380-1387. PubMed ID: 30569091
[TBL] [Abstract][Full Text] [Related]
17. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma.
Zhao X; Liu Y; Li Z; Zheng S; Wang Z; Li W; Bi Z; Li L; Jiang Y; Luo Y; Lin Q; Fu Z; Rufu C
J Cell Mol Med; 2018 Jan; 22(1):655-667. PubMed ID: 28984028
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.
Hang C; Gong C; Fang Y; Chen L; Zhu J
J Mol Histol; 2021 Apr; 52(2):187-196. PubMed ID: 33394290
[TBL] [Abstract][Full Text] [Related]
19. S100A11, a putative tumor suppressor gene, is overexpressed in pancreatic carcinogenesis.
Ohuchida K; Mizumoto K; Ohhashi S; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Clin Cancer Res; 2006 Sep; 12(18):5417-22. PubMed ID: 17000675
[TBL] [Abstract][Full Text] [Related]
20. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma.
Li W; Chen C; Zhao X; Ye H; Zhao Y; Fu Z; Pan W; Zheng S; Wei L; Nong T; Li Z; Chen R
J Cell Mol Med; 2017 Nov; 21(11):2896-2908. PubMed ID: 28544376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
